Testimony was expected to begin today.
The 52-year-old former teacher had sought $110 million.
Attorneys for both sides met Wednesday in Houston, Hill said.
The Madison, N.J.-based company is the nation's seventh-largest pharmaceutical company.
Sheller said he thought the case would be settled.
The combination became known as fen-phen.
Pending a judge's approval, initial payments will begin later this year.
Interneuron is now facing more than 2,000 lawsuits related to Redux.
But the settlement has not been finalized, and attorneys said many clients will opt-out of the agreement so they can sue on their own.
CAMBRIDGE, Mass. American Home Products' Wyeth-Ayerst Laboratories division marketed the "fen" drugs fenfluramine and dexfenfluramine, which were combined with phentermine to make "fen-phen." It did not cover Linnen, who suffered primary pulmonary hypertension, said Alex Zisson, an industry analyst with Hambrecht Quist.
Edward F. Blizzard, an attorney for a group of fen-phen users who object to the settlement, wants the judge to throw it out.
''The amounts being offered to settle these claims are inadequate to compensate people for their injuries.'' More than 9,000 lawsuits have been filed against American Home Products, maker of fenfluramine, the ''fen'' in the fen-phen diet drug combination.
The drugs were withdrawn in September 1997 after a Mayo Clinic study linked fen-phen to potentially fatal heart valve damage.
The settlement also includes money for their future medical monitoring.
The plaintiffs also name the manufacturers of the ``phen'' part of the combination, but a panel of state district judges has ruled
